Research and Markets: Gestational Diabetes Global Clinical Trials Review, Q1, 2011

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/84f006/gestational_diabet) has announced the addition of GlobalData 's new report "Gestational Diabetes Global Clinical Trials Review, Q1, 2011" to their offering.

“Gestational Diabetes Global Clinical Trials Review, Q1, 2011”

Gestational Diabetes Global Clinical Trials Review, Q1, 2011 provides data on the Gestational Diabetes Global clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Gestational Diabetes . It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts.

Scope

• Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status and trial success rate
• Review of key discontinued trials (suspended, withdrawn and terminated)
• Overview of the enrollment pattern by phase for the past decade

Key Topics Covered:

• 1.1 List of Tables
• 1.2 List of Figures
• 2. Introduction
• 3. Unaccomplished Trials of Gestational Diabetes
• 4. Prominent Sponsors
• 5. Prominent Drug Comparison
• Appendix

For more information visit http://www.researchandmarkets.com/research/84f006/gestational_diabet